Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 60219-2095

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 60219-2095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 1)

Chemical structure diagram of the active ingredient Emtricitabine, showing the molecular arrangement of atoms and bonds.*

FDA Label Image

10 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 2)

Chemical structure of Tenofovir Disoproxil Fumarate, an active ingredient in Emtricitabine and Tenofovir Disoproxil Fumarate tablets by Amneal Pharmaceuticals.*

FDA Label Image

1 (Emtricitabine And Tenofovir Disoproxil Fumarate Ta 3)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg by Amneal Pharmaceuticals LLC. The film-coated tablets are oral dosage form, with 30 tablets per container. The label includes storage instructions, barcode, and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.